Clinical Investigator Administrative Actions – Disqualification
Clinical Investigator Administrative Actions – Disqualification Guidance document is intended to inform institutional review boards (IRBs), clinical investigators, and sponsors about the administrative action…
Read more →Decentralized Clinical Trials for Drugs, Biological Products, and Devices
Decentralized Clinical Trials for Drugs, Biological Products, and Devices draft guidance provides recommendations for sponsors, investigators, and other stakeholders regarding the implementation of decentralized…
Read more →Informed Consent Guidance for IRBs, Clinical Investigators, and Sponsors
Informed Consent Guidance for IRBs, Clinical Investigators, and Sponsors guidance is intended to assist institutional review boards (IRBs), clinical investigators, and sponsors in complying…
Read more →Providing Submissions in Electronic Format Post marketing Safety Reports
Providing Submissions in Electronic Format Post marketing Safety Reports guidance is one in a series of guidance documents intended to assist industry when making…
Read more →Assessing the Effects of Food on Drugs in INDs and NDAs Clinical Pharmacology Considerations
Assessing the Effects of Food on Drugs in INDs and NDAs Clinical Pharmacology Considerations this guidance provides recommendations to sponsors planning to conduct food-effect…
Read more →